isosteviol has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, F; Lu, Z; Lun, J; Song, L; Sun, T; Sun, X; Tan, W; Zhao, H; Zhou, C | 1 |
| Davey, AK; Evans, AM; Li, Y; Wang, J; Xu, D; Zhang, S | 1 |
2 other study(ies) available for isosteviol and Cardiovascular Stroke
| Article | Year |
|---|---|
Isosteviol improves cardiac function and promotes angiogenesis after myocardial infarction in rats.
Topics: Animals; Diterpenes, Kaurane; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Myocardial Infarction; Neovascularization, Physiologic; Rats; Vascular Endothelial Growth Factor A; X-Ray Microtomography; Zebrafish | 2022 |
The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury.
Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Decanoic Acids; Disease Models, Animal; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Heart Rate; Hydroxy Acids; Injections, Intravenous; Myocardial Infarction; Myocardial Reperfusion Injury; Pyrazines; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Ventricular Fibrillation | 2007 |